Predictors of Death in Severe COVID-19 Patients at Millennium COVID-19 Care Center in Ethiopia: a Case-control Study
Overview
Authors
Affiliations
Introduction: as the number of new cases and death due to COVID-19 is increasing, understanding the characteristics of severe COVID-19 patients and identifying characteristics that lead to death is a key to make an informed decision. In Ethiopia, as of September 27 2020, a total of 72,700 cases and 1165 deaths were reported. Therefore, the study aimed to assess the determinants of death in severe COVID-19 patients admitted to millennium COVID-19 care center in Ethiopia.
Methods: a case-control study of 147 severe COVID-19 patients (49 deaths and 98 discharged alive cases) was conducted from August to September 2020. A comparison of underlying characteristics between cases (death) and controls (alive) was assessed using a chi-square test and an independent t-test with a p-value of <0.05 considered as having a statistically significant difference. Multivariable binary logistic regression was used to identify predictors of severe COVID-19 outcome (alive vs death) where adjusted odds ratio (AOR), 95% confidence interval (CIs) for AOR, and P-values were used for testing significance and interpretation of results.
Results: having diabetes mellitus (AOR= 3.257, 95%CI=1.348,7.867, p-value <0.001), fever (AOR=0.328, 95%CI= 0.123,0.878, p-value=0.027) and shortness of breath (AOR=4.034, 95%CI=1.481,10.988, p-value=0.006) were found to be significant predictors of death in severe COVID-19 patients.
Conclusion: the outcome of death in severe COVID-19 patients is found to be associated with exposures to being diabetic and having shortness of breath at admission. On the other hand, having a fever at admission was associated with a favorable outcome of being discharged alive.
Survival of hospitalised COVID-19 patients in Hawassa, Ethiopia: a cohort study.
Anteneh A, LeBlanc M, Natnael A, Asfaw Z BMC Infect Dis. 2024; 24(1):1055.
PMID: 39333929 PMC: 11429985. DOI: 10.1186/s12879-024-09905-w.
Belayneh E, Workneh Leulseged T, Teklu B, Tewodros B, Megiso M, Weldesenbet E Cureus. 2024; 16(8):e67719.
PMID: 39318914 PMC: 11421194. DOI: 10.7759/cureus.67719.
Mussie K, Setchell J, Kaba M, Elger B SAGE Open Med. 2024; 12:20503121241263305.
PMID: 39092158 PMC: 11292689. DOI: 10.1177/20503121241263305.
Diabetes mellitus in sub-saharan Africa during the COVID-19 pandemic: A scoping review.
Sseguya W, Bahendeka S, MacLennan S, Mody N, Guntupalli A PLoS One. 2024; 19(7):e0305112.
PMID: 38976666 PMC: 11230555. DOI: 10.1371/journal.pone.0305112.
Determinants of COVID-19 severity in Ethiopia: a multicentre case-control study.
Tadie M, Yimer Y, Taye G BMJ Open. 2024; 14(5):e083076.
PMID: 38803268 PMC: 11328661. DOI: 10.1136/bmjopen-2023-083076.